These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17654367)

  • 1. Has the spread of HPV vaccine marketing conveyed immunity to common sense?
    McGee G; Johnson S
    Am J Bioeth; 2007 Jul; 7(7):1-2. PubMed ID: 17654367
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the failure of human papillomavirus vaccine state requirements.
    Schwartz JL; Caplan AL; Faden RR; Sugarman J
    Clin Pharmacol Ther; 2007 Dec; 82(6):760-3. PubMed ID: 17971822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical companies' role in state vaccination policymaking: the case of human papillomavirus vaccination.
    Mello MM; Abiola S; Colgrove J
    Am J Public Health; 2012 May; 102(5):893-8. PubMed ID: 22420796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mandatory HPV vaccination and political debate.
    Gostin LO
    JAMA; 2011 Oct; 306(15):1699-700. PubMed ID: 21979129
    [No Abstract]   [Full Text] [Related]  

  • 5. Who should get the HPV vaccine? Usage expands amid debate.
    Peres J
    J Natl Cancer Inst; 2010 Jun; 102(12):838-40. PubMed ID: 20530765
    [No Abstract]   [Full Text] [Related]  

  • 6. Push to mandate HPV vaccine triggers backlash in USA.
    Udesky L
    Lancet; 2007 Mar; 369(9566):979-80. PubMed ID: 17387782
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug companies agree to cut price of HPV vaccine to developing countries to increase accessibility.
    Gulland A
    BMJ; 2013 May; 346():f3025. PubMed ID: 23667128
    [No Abstract]   [Full Text] [Related]  

  • 8. Marketing and the HPV vaccine.
    Massad LS
    JAMA; 2009 Dec; 302(24):2660; author reply 2661. PubMed ID: 20040551
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs, sex, money and power: an HPV vaccine case study.
    Haas M; Ashton T; Blum K; Christiansen T; Conis E; Crivelli L; Lim MK; Lisac M; Macadam M; Schlette S
    Health Policy; 2009 Oct; 92(2-3):288-95. PubMed ID: 19505744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health, public trust and lobbying.
    Wynia MK
    Am J Bioeth; 2007 Jun; 7(6):4-7. PubMed ID: 17558977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
    Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
    J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV vaccine strategies: the cost of HPV and the choice of vaccine.
    Morris SR
    Sex Transm Infect; 2009 Sep; 85(5):315-6. PubMed ID: 19773455
    [No Abstract]   [Full Text] [Related]  

  • 14. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy undermines support for state mandates on the human papillomavirus vaccine.
    Gollust SE; Dempsey AF; Lantz PM; Ubel PA; Fowler EF
    Health Aff (Millwood); 2010 Nov; 29(11):2041-6. PubMed ID: 21041746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient-consumer-advocate nexus: the marketing and dissemination of gardasil, the human papillomavirus vaccine, in the United States.
    Gottlieb SD
    Med Anthropol Q; 2013 Sep; 27(3):330-47. PubMed ID: 24248992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAVI injects new life into HPV vaccine rollout.
    Lancet; 2013 May; 381(9879):1688. PubMed ID: 23683613
    [No Abstract]   [Full Text] [Related]  

  • 18. Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil.
    Tomljenovic L; Shaw CA
    J Law Med Ethics; 2012; 40(3):673-81. PubMed ID: 23061593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marketing and the HPV vaccine.
    Betensky M
    JAMA; 2009 Dec; 302(24):2660-1; author reply 2661. PubMed ID: 20040550
    [No Abstract]   [Full Text] [Related]  

  • 20. Marketing HPV vaccine: implications for adolescent health and medical professionalism.
    Rothman SM; Rothman DJ
    JAMA; 2009 Aug; 302(7):781-6. PubMed ID: 19690311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.